By Ian Walker
Science Group PLC said Friday that it has increased its shareholding in U.K. engineering company TP Group PLC to 23.15% from 20.9%.
The shareholding, which was disclosed in a regulatory filing, is worth 11.7 million pounds ($16 million) based on the current offer proposal price of 6.5 pence. Science Group now owns 180.4 million TP Group shares, up from 140.5 million. Earlier this week Science Group increased its shareholding from 18.03%.
On Tuesday, the science-led services and product development company said it didn’t plan to increase its GBP50.6 million takeover proposal for TP Group and therefore declared it final.
Science Group made the disclosure after TP Group rejected its latest 6.5 pence-a-share proposal late Monday.
Science Group also reiterated that if the TP Group board continues its refusal to cooperate and Science Group is unable to proceed with an offer, then it will keep its shareholding as a strategic investment and “adopt an active engagement strategy in relation to its investment.” The company won’t consider any offers for its shares in TP Group from third parties, it said.
Best Heal Care Stocks To Watch For 2023: Galmed Pharmaceuticals Ltd.(GLMD)
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of liver diseases. It is developing Aramchol, which is in Phase IIb clinical trial for the treatment of non-alcoholic steato-hepatitis in patients who also suffer from obesity and insulin resistance. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.
- [By Max Byerly]
Bank of New York Mellon Corp decreased its position in shares of Quidel Co. (NASDAQ:QDEL) by 49.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 160,164 shares of the company’s stock after selling 154,544 shares during the period. Bank of New York Mellon Corp’s holdings in Quidel were worth $7,819,000 as of its most recent SEC filing.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Quidel (QDEL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com